logo

Oncternal Therapeutics Inc. (ONCT)



Trade ONCT now with
  Date
  Headline
1/14/2021 8:13:20 AM Oncternal Confirms Lentigen To Manufacture Lentiviral Vectors For ROR1-targeting CAR-T Program
10/6/2020 8:07:08 AM Oncternal Therapeutics Gets Rare Pediatric Disease Designation From FDA For TK216 For Treatment Of Ewing Sarcoma
9/22/2020 7:07:39 AM Milestone Pharma Appoints Lisa Giles And Robert Wills To Board, Effective October 1
9/22/2020 7:01:39 AM Milestone Pharmaceuticals Appoints Lisa Giles And Robert Wills To Its Board
9/21/2020 8:16:06 AM Oncternal Presents Interim Phase 1 Trial Data For TK216 In Patients With Relapsed/Refractory Ewing Sarcoma
6/30/2020 7:47:21 AM Oncternal Therapeutics Announces Updated Clinical Strategy For ROR1 Monoclonal Antibody, Cirmtuzumab
5/7/2020 8:16:18 AM Oncternal Q1 Net Loss $4.7 Mln Or $0.31/Shr
3/11/2020 8:04:23 AM Oncternal Reports Interim Data Update For Cirmtuzumab In Combination With Ibrutinib In Mantle Cell Lymphoma